Evaluation of the Safety and Tolerability of Niraparib With Everolimus in Advanced Gynecologic Malignancies and Breast

NCT03154281 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

14

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Ovarian Cancer

Interventions

DRUG: niraparib
DRUG: everolimus

Sponsor

Avera McKennan Hospital & University Health Center